menu
    • menu

    Company profile for FibroGenesis

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Based in Houston, Texas, FibroGenesis, is a regenerative medicine company developing an innovative solution for chronic disease treatment using human dermal fibroblasts. Currently, FibroGenesis holds 186 U.S. and international issued patents/patents pending across a variety of clinical pathways, including Disc Degeneration, Multiple Sclerosis, Parkinson's, Chronic Traumatic Encephalopathy, Cancer, Diabetes, Liver Failure and H...
    Based in Houston, Texas, FibroGenesis, is a regenerative medicine company developing an innovative solution for chronic disease treatment using human dermal fibroblasts. Currently, FibroGenesis holds 186 U.S. and international issued patents/patents pending across a variety of clinical pathways, including Disc Degeneration, Multiple Sclerosis, Parkinson's, Chronic Traumatic Encephalopathy, Cancer, Diabetes, Liver Failure and Heart Failure. Funded entirely by angel investors, FibroGenesis represents the next generation of medical advancement in cell therapy.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    FibroGenesisUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    16815 Royal Crest Drive, Suite 100 Houston, TX 77058
    Telephone
    Telephone
    281-461-6211
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.fibro-genesis.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Chemomab Presents Clinical Data from Investigator-Initiated Study CM-101
    Chemomab Presents Clinical Data from Investigator-Initiated Study CM-101

    09 Nov 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/chemomab-presents-clinical-data-from-investigator-initiated-study-showing-cm-101-reduced-inflammatory-and-fibrogenesis-related-biomarkers-in-patients-with-severe-lung-injury-derived-from-covid-19-301672588.html

    PRNEWSWIRE
    09 Nov 2022
    Share Share
    FibroGenesis Reports Breakthrough in Prevention of COVID-19 Blood Clotting
    FibroGenesis Reports Breakthrough in Prevention of COVID-19 Blood Clotting

    12 Aug 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/08/12/2077255/0/en/FibroGenesis-Reports-Breakthrough-in-Prevention-of-COVID-19-Blood-Clotting.html

    GLOBENEWSWIRE
    12 Aug 2020
    Share Share
    FibroGenesis Identifies Mechanism Responsible for Blocking COVID19-Like Lung
    FibroGenesis Identifies Mechanism Responsible for Blocking COVID19-Like Lung

    01 Jul 2020

    // PRNASIA

    https://en.prnasia.com/releases/global/fibrogenesis-identifies-mechanism-responsible-for-blocking-covid19-like-lung-inflammation-284313.shtml

    PRNASIA
    01 Jul 2020
    Share Share
    FibroGenesis Reports COVID-19 Breakthrough Using Fibroblast Cell Therapy
    FibroGenesis Reports COVID-19 Breakthrough Using Fibroblast Cell Therapy

    22 May 2020

    // PRNASIA

    https://en.prnasia.com/releases/global/fibrogenesis-reports-covid-19-breakthrough-using-fibroblast-cell-therapy-pre-clinical-trial-phase--280763.shtml

    PRNASIA
    22 May 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search